Evaluating of the Impact of a Connected and Non-intrusive Device in Improving the Screening of Sleep Apnea Syndrome and the Addressing of Potentially Pathological Patients in Hospital Environment (AMELIAS)

NCT06141967 NA COMPLETED

Diabetes, obesity and metabolic syndrome are closely linked to sleep apnea syndrome. Indeed, diabetic and/or obese patients present an increased risk of sleep apnoea syndrome (SAS), with a prevalence estimated at between 10 and 22%, depending on the study, and most of them requiring treatment with Continuous Positive Airway Pressure (CPAP). In this sub-population of patients, only between 40% and 50% benefit from CPAP.

Details

Lead sponsor	Centre Hospitalier Universitaire de Saint Etienne
Phase	NA
Status	COMPLETED
Enrolment	600
Start date	Thu Nov 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Jul 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Sleep Apnea Syndromes
• Metabolic Syndrome
• Diabetes
• Obese

Interventions

• WITHINGS Sleep Analyzer

Countries

France